SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001640334-19-000196
Filing Date
2019-02-08
Accepted
2019-02-08 16:40:15
Documents
1
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2842
  Complete submission text file 0001640334-19-000196.txt   4194
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10609 RIVER OAKS LANE POTOMAC MD 20859
Business Address
Ganjei James Kelly (Reporting) CIK: 0001767300 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38793 | Film No.: 19580508